Surgical Result for Patients Who Simultaneously Presented With Myasthenia Gravis and Thymoma [PDF]
Background Patients who present concurrently with thymoma and myasthenia gravis (MG) constitute a unique clinical population in whom both oncologic control and stabilization of MG symptoms are essential treatment goals.
Po‐Chun Chang +7 more
doaj +4 more sources
Thymomectomy Plus Total Thymectomy Versus Simple Thymomectomy for Early-Stage Thymoma Without Myasthenia Gravis: A European Society of Thoracic Surgeons Thymic Working Group Study. [PDF]
Abstract OBJECTIVESResection of thymic tumours including the removal of both the tumour and the thymus gland (thymothymectomy; TT) is the procedure of choice and is recommended in most relevant articles in the literature. Nevertheless, in recent years, some authors have suggested that resection of the tumour (simple thymomectomy; ST) may suffice from ...
Bernhard Zdársky +2 more
exaly +21 more sources
Whether thymectomy (TM) or thymomectomy (TMM) is better for non-myasthenic patients with early-stage thymoma. We conducted a meta-analysis to compare the clinical outcomes and prognoses of non-myasthenic patients with early-stage thymoma treated using ...
Congcong Xu +12 more
doaj +6 more sources
Thymomectomy Versus Complete Thymectomy in Early-Stage Non-Myasthenic Thymomas: A Multicentric Propensity Score-Matched Study. [PDF]
Abstract OBJECTIVES Thymomectomy is gaining consensus over complete thymectomy in early-stage thymoma without myasthenia gravis. This is due both to the difficulty of establishing prospective and randomized controlled studies and to the lack of well-defined selection criteria.
Marco Alloisio +2 more
exaly +8 more sources
Prognostic factors and role of postoperative radiotherapy in surgically resected thymomasCentral MessagePerspective [PDF]
Objective: To investigate the prognostic factors in and role of postoperative radiotherapy (PORT) for surgically resected thymomas. Methods: A total of 1540 patients with pathologically confirmed thymomas undergoing resection between 2000 and 2018 were ...
Fujun Yang, MD +10 more
doaj +3 more sources
Corrigendum to 'Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: a European Society of Thoracic Surgeons Thymic Working Group Study'. [PDF]
In the original version of this article, the last name of collaborator Giorgio Lo Iacono was misspelled. This has now been corrected above and in the full article.
Guerrera F +50 more
europepmc +9 more sources
A Case Report of Good’s Syndrome Diagnosed After Thymomectomy [PDF]
Good's syndrome is a rare immunodeficiency disorder associated with thymoma, characterized primarily by hypogammaglobulinemia and B-cell deficiency. Patients with Good's syndrome exhibit compromised immunity, rendering them highly susceptible to recurrent infections.
Chee Yik Chang
exaly +4 more sources
Radical Thymectomy Versus Conservative Thymomectomy in the Surgical Treatment of Thymic Malignancies [PDF]
Complete thymectomy is recommended for thymic malignancies to reduce local recurrence and the likelihood of the long-term development of myasthenia gravis (MG). Thymus-conserving surgery (thymomectomy) seems to yield similar results, but evidence is still limited. The objective of this study was to assess if the oncological outcome, in terms of overall
Pierluigi Novellis +2 more
exaly +5 more sources
Thymoma-associated anti-LGI1 encephalitis and myasthenia gravis: A unique combination with autoantibodies [PDF]
We report a 77-year-old woman with a thymoma, anti-LGI1antibody associated encephalitis (LGI1 encephalitis), and MG accompanied by positive anti-acetylcholine receptor antibodies (AchR Ab) and anti-titin antibodies (titin Ab).
Akane Satake +8 more
doaj +2 more sources
Oncological Outcomes of Complete Versus Limited Thymectomy in Early Stage Thymic Epithelial Tumors: A Systematic Review and Individual Patient Data Meta-Analysis [PDF]
Objectives: To clarify the role of limited versus complete thymectomy in stage I thymic epithelial tumors (TETs) using standardized survival measures and predefined oncological outcomes.
Riccardo Tajè, MD +15 more
doaj +2 more sources

